Overall, this is an interesting paper on trends in prevalence of birth defects. The paper would benefit from an English language review, in addition to addressing the comments below:
throughout the paper. Also, the denominator (total number of births) is not listed anywhere.
The authors state that maternal age increases account for the increase in chromosomal anomalies. I would like to see this further explored by analyses stratified by maternal age. One would expect that the prevalences by age group would not change if the difference is solely due to changes in maternal age (assuming the age ranges are sufficiently narrow within each group). (The authors did address this by adjusting for maternal age, but this data is not shown. I think stratified analyses would be clearer.)
Discussion: Study limitations need to be addressed.
Spelling errors: -First sentence of abstract: "Toestimate" -Introduction header -32,1 in Results section of abstract -First sentence of 2nd paragraph of discussion: "ofthis" -some of the "%" symbols are not correct (extra circle at bottom) -Discussion header Introduction Second para: 17-UE -is that not meant to be EU-17? Second para: "differences in countries up to 5 years." -"of up to 5 years" might help. Second para: "in Spain and other countries" might be better in parenthesis rather than commas. Second para: "enable presently to conduct more" might be better as "allow for more" Third para: what is the synthetic index of fecundity? Some elaboration of what is shows might help.
Methods
First para: "study period has been" should read "study period was" Second para: "excepting" should be "excluding" Second para: "One case with several non chromosomal... within each one" -this sentence is not entirely clear. I understand that for confidentiality reasons you cannot be overly specific, but the phrasing does not really capture what is meant. Third para: "for they are flexible models with no restrictions" could be written "as they are flexible unrestricted models" Third para: it's not clear why maternal age was included as a categorical variable rather than continuous, given the volume of cases available. Some justification could be provided.
Results
First para: is 51,771 the figure for three years (1999) (2000) (2001) or the average annual figure? First para: "age of motherhood moved into later ages" should be "average age of motherhood increased" or something similar. First para: "mother age indicators keep closer to those of all births" could be "maternal age indicators were similar to those for all births" Table 1 : 32,1 should be 32.1 Table 1 : would it not make sense to have 35-39 years and 40+ rather than 40+ being a subset of 35+? Third para: when you quote cases per 1000 births, it is not clear what you denominator is, could you clearly state the total number of births in the 10 year period (maybe in the first paragraph). Third para: it wouldn't hurt to put a second decimal place on the rates per 1000, as they look overly precise at the moment. Fifth paragraph: "with the exception of" rather than "excepting" Sixth paragraph: "except for the urinary subgroups, which increased between 1999 and 2003" Discussion Second para: "This makes the data" should read "As a consequence the data are highly reliable and have improved comparability..." Third para: "as trends are no longer statistically significant" Fourth para: "a positive diagnosis" and "an antenatal diagnosis" Fifth para: "rates are 20% lower in the Basque Country" Sixth para: you state that your findings are consistent with the reports of U-and J-curves with maternal age. It's not clear where you report this in the results. Your only plots by maternal age are histograms of frequencies, so a U-or J-curve cannot be discerned. Seventh paragraph: the sentence "Taking into account ... observed increase" needs to be rewritten for readability. Tenth para: "there is spatial clustering" Overall, this is an interesting paper on trends in prevalence of birth defects. The paper would benefit from an English language review, in addition to addressing the comments below: 1)I would not use the term "evolution" to describe the change in prevalence over time.
Figures
We have changed the term evolution for trend over time 2) Results section of Abstract: need to be clear whether discussing diagnosed cases or live births only. In the new version we have included the term 'total' when referring to total diagnosed anomalies, to distinguish them from the anomalies at birth.
3) How diagnosed cases are assessed needs to be spelled out in the abstract (Participants section or elsewhere). We have included a new sentence in Participants section. Also we have added in the first paragraph of Methods that the staff of the Registry checks all the medical records of prenatal diagnosis and code all the cases. 4)Also, what is the denominator for % calculations? All live births? The numerator includes pregnancies not included in the denominator (e.g., fetal losses, miscarriages, terminations)--this should be addressed somewhere in the paper. This point is addressed in the second paragraph of Methods, where the calculations of total prevalences and prevalences at birth are given in detail 5) Unless absolutely necessary, I would prefer to avoid the abbreviation CA for congenital anomalies. Ok. Thank you, all the abbreviations CA have been removed 6)Methods: I am not sure if all readers will be familiar with the CIE coding--including the corresponding ICD-10 codes might be helpful. Sorry, CIE is the Spanish Acronym for ICD. It has been corrected in the text.
7)It would also be helpful to have a table listing the defects included in the study by group (nervous system, etc.) and number of cases in each group. The Subgroups of anomalies we have studied are those established in the Eurocat project. In the new version we cite a bibliographic reference for those interested in knowing further details of the subgroups (Boyd PA, Haeusler M, Barisic I, et al. Paper 1: The EUROCAT network--organization and processes. Birth Defects Res A Clin Mol Teratol 2011;91 Suppl 1:S2-15). 8)Were the subgroups not analyzed individually still included in the analysis of total anomalies? I believe so, but the wording makes this confusing. Yes, in fact, the subgroups we have analyzed are those for which ICD-10 codes are given. 9)Also, a reference is needed for the study. A brief description of the study methods is needed--for example, how are cases confirmed/reviewed, especially for those that are prenatally diagnosed? . In the first paragraph of Methods we have added the following sentence: "The staff of the Registry routinely check Hospital Discharge Databases and the Registry of Terminations of Pregnancies searching for new cases, review medical reports of prenatal diagnosis (sonography, genetic test and pathology) and code all congenital anomalies." 10)Abstract and Results: Table 2 lists prevalences as per 1000, but they are listed as percentages in the text, without correction--the percentages listed in the text appear to be incorrect. This occurs throughout the paper.
All prevalences are given per 1000 births,in the text, in the table and in the graphs. To avoid repeating 'per 1000' in the text, we use the symbol ‰ (per mille). We have checked both the pdf created and the html version of the uploaded manuscript, and in both versions the symbol is properly displayed. 11)Also, the denominator (total number of births) is not listed anywhere. Certainly. The total number of births in the study period (191, 171) has been included in the new version in the 1st paragraph of Results 12)The authors state that maternal age increases account for the increase in chromosomal anomalies. I would like to see this further explored by analyses stratified by maternal age. One would expect that the prevalences by age group would not change if the difference is solely due to changes in maternal age (assuming the age ranges are sufficiently narrow within each group). (The authors did address this by adjusting for maternal age, but this data is not shown. I think stratified analyses would be clearer.)
The results of the stratified analysis are similar to those of multivariate models. As shown in table A1, the prevalences of total diagnosed chromosomal anomalies and Down Syndrome in the study periods are quite the same. Accordingly, calendar year is not statistically significant in any of the age-specific regression models. DS* 101 13.9(11.4,17.0) 14.6 (9.2,22.9) 13.7(9.9,18.7) DS_F** 72 9.9(7.8412.6) 10. 26 (5.84,17.59) 9.7(6.67,14.1) In our view, the stratified analysis may be clearer than adjusting for age group when the number of strata and the number of outcomes studied are not high. However, we do not think this is the case of our study. In a stratified analysis we would have 17 different outcomes and 3 or 4 maternal age groups, i.e. 51-68 results. As we are focusing on the trend, and maternal age is an adjusting factor, we think that results from the multivariate model are a better option, because they are more easily reported and more clearly understood. The paper has a succinct aim and largely achieves that. There are some minor points regarding data that could be added and it is not clear that they have supplied all the results to support their comments in the Discussion. The text needs to be checked for style, as certain phrases do not read well. Perhaps the help of a native English speaker could help. 1) Use "maternal age" rather than "mother age" "Non chromosomal" might be better hyphenated (i.e., "non-chromosomal") Thank you very much for all of your suggestions and corrections of style Specific points 2) Abstract In Results the comma in 32,1 needs to be a full stop. In Conclusion, "and still keep slightly increasing" could be phrased "and continue to increase slightly." In Conclusion, it is stated that the increasing prevalence "can be related to the rise in maternal age." Are the authors claiming an unequivocal direct causal relationship or speculating. If the former, then they might state "is related." Otherwise, "may be related" would be better. Corrected. Thank you 3) Introduction Second para: 17-UE -is that not meant to be EU-17? Second para: "differences in countries up to 5 years." -"of up to 5 years" might help. Second para: "in Spain and other countries" might be better in parenthesis rather than commas. Second para: "enable presently to conduct more" might be better as "allow for more" OK. Thank you very much 4)Third para: what is the synthetic index of fecundity? Some elaboration of what is shows might help. In the new version, we have added a definition of the synthetic index of fecundity, as provided by the Basque Statistics Institute: an estimation of the number of children a hypothetical woman would have at the end of her fertile life if her fecundity corresponded to the age-specific fecundity rates of the population) Methods 5)First para: "study period has been" should read "study period was" OK Second para: "excepting" should be "excluding" OK 6)Second para: "One case with several non chromosomal... within each one" -this sentence is not entirely clear. I understand that for confidentiality reasons you cannot be overly specific, but the phrasing does not really capture what is meant. We meant to say that the cases with more than one non-chromosomal anomalies of different subgroups count only as one case in each subgroup, and also as one case for total non-chromosomal anomalies. We have rewritten the sentence in the text. We hope it is clearer now. 7) Third para: "for they are flexible models with no restrictions" could be written "as they are flexible unrestricted models" OK 8) Third para: it's not clear why maternal age was included as a categorical variable rather than continuous, given the volume of cases available. Some justification could be provided.
13)Discussion
We think that the categorical variable (age group) is more accurate than the continuous one. The use of continuous variable implies that the relationship between age and the risk of anomalies is linear (or loglinear) but the categorical one allows for different relationships. Both for chromosomal and nonchromosomal anomalies non linear relationships have been described, an exponential increase at 30-35 years in chromosomal anomalies, and a slight J or U shaped relationship for non-chromosomal anomalies.
. Results 9)First para: is 51,771 the figure for three years (1999) (2000) (2001) or the average annual figure?
We have rephrased the first sentence and included the total number of births in the study period. 10) First para: "age of motherhood moved into later ages" should be "average age of motherhood increased" or something similar. OK First para: "mother age indicators keep closer to those of all births" OK could be "maternal age indicators were similar to those for all births" OK Table 1 : 32,1 should be 32.1 OK 11) Table 1 : would it not make sense to have 35-39 years and 40+ rather than 40+ being a subset of 35+? Because of maternal age is the main risk factor for chromosomal anomalies and 35 years is an agelimit used for screening purposes, we think that some readers may expect to find the frequencies for >35 years instead the frequency for 35-39 yrs. Anyway, adding or subtracting columns can obtain the lacking complementary result 12)Third para: when you quote cases per 1000 births, it is not clear what you denominator is, could you clearly state the total number of births in the 10 year period (maybe in the first paragraph). In the new version we have included the total number of births in the first paragraph. In table 2 we indicate that prevalence are /1000 births 13)Third para: it wouldn't hurt to put a second decimal place on the rates per 1000, as they look overly precise at the moment. Thanks. In the new version results are given with two decimals 14) Fifth paragraph: "with the exception of" rather than "excepting" OK Sixth paragraph: "except for the urinary subgroups, which increased between 1999 and 2003" OK Discussion 15) Second para: "This makes the data" should read "As a consequence the data are highly reliable and have improved comparability..." Third para: "as trends are no longer statistically significant" Fourth para: "a positive diagnosis" and "an antenatal diagnosis" Fifth para: "rates are 20% lower in the Basque Country" 16)Sixth para: you state that your findings are consistent with the reports of U-and J-curves with maternal age. It's not clear where you report this in the results. Your only plots by maternal age are histograms of frequencies, so a U-or J-curve cannot be discerned. In the new version of this paragraph we have included age-group prevalence rates (and 95%CI) of total non-chromosomal anomalies. 17)Seventh paragraph: the sentence "Taking into account ... observed increase" needs to be rewritten for readability. We have rephrased the paragraph. We hope it is clear now Tenth para: "there is spatial clustering" OK Figures 18) Figures 2 and 3 : you need a footnote to explain the the lines of fit OK. We also have included the explanations in the titles (that error bars are calculated for each calendar year and that the lines of fit are those of GAM models)
VERSION 2 -REVIEW

REVIEWER
Conor Teljeur Trinity College Dublin, Ireland REVIEW RETURNED 06-Jan-2014
GENERAL COMMENTS
Two very minor points: Page 4, line 24 -should be phrased "can be found elsewhere" rather than "can be found somewhere else". 
-"evolution" still needs to be changed to "trend over time" in the some places (e.g., twice in the abstract) -CA abbreviation still used in some places -Even if the stratified analyses are not shown in a table, it would be helpful to discuss these results. It would be interesting to note, for example, whether the decrease in prevalence at birth for DS and chromosomal abnormalities overall occurs in all age categories or only in the 35 and over ones.
-Maternal age could be included as a continuous variable. A nonlinear relationship could be addressed using a quadratic or higher order term in the model (e.g., maternal age x maternal age). However, this would make the interpretation of results more difficult. It would be possible to look at a model with age as a continuous variable and discuss it but to present the categorical.
-The authors stated that they addressed the fact that the numerator includes pregnancies not included in the denominator (e.g., fetal losses, miscarriages, terminations) in the second paragraph of Methods, but this point is not addressed there and would be more appropriate in the discussion--i.e., the fact that the denominator would ideally include all pregnancies, not just all live births.
-The study limitations are not fully addressed in the discussion.
-It would be helpful to have a table listing the defects included in the study by group (nervous system, etc.) with the number of cases in each group. Having these numbers readily available for the reader would be preferable to a reference.
VERSION 2 -AUTHOR RESPONSE
Reviewer Name Conor Teljeur Institution and Country Trinity College Dublin, Ireland Please state any competing interests or state 'None declared': None declared.
The requested corrections have been adequately addressed.
Two very minor points: 1. Page 4, line 24 -should be phrased "can be found elsewhere" rather than "can be found somewhere else". Ok Thank you -"evolution" still needs to be changed to "trend over time" in the some places (e.g., twice in the abstract).
We were using ' evolution' as a term to refer to changes of prevalences over time without necessarily implying any pattern, and 'trend' to refer to changes in prevalences that follow a pattern over time, and are not likely random or spurious. Anyway, we have avoided the use of evolution in text.
2.-CA abbreviation still used in some places -All CA have been removed except for those of table 1, because of lack of space.
3. Even if the stratified analyses are not shown in a table, it would be helpful to discuss these results. It would be interesting to note, for example, whether the decrease in prevalence at birth for DS and chromosomal abnormalities overall occurs in all age categories or only in the 35 and over ones.
In the stratified analysis no statistically significant changes are observed, except for the prevalences at birth in the group of mothers between 30-34 years, in which we have found a significant decrease in the prevalence of chromosomal anomalies at birth (p=0.031). This result has been added in the fourth paragraph of Results.
4.-Maternal age could be included as a continuous variable. A non-linear relationship could be addressed using a quadratic or higher order term in the model (e.g., maternal age x maternal age). However, this would make the interpretation of results more difficult. It would be possible to look at a model with age as a continuous variable and discuss it but to present the categorical.
The use of age as a continuous variable would necessary imply second or higher order terms, since the relationship between age and the log-risk of anomalies is not linear. Even so the restrictions of the parametric modeling are important. An exponential increase at 35 years in chromosomal anomalies, and a slight J or U shaped relationship for non-chromosomal anomalies have been reported. As the reviewer points out using second or higher order terms would make the interpretation of the results more difficult, and it would not give interpretable estimates for maternal age groups. On the contrary, in our view, the use of age as a categorical variable with narrow age groups (5 years) provides risk estimates for each age group and also good adjustment of trends.
5.-The authors stated that they addressed the fact that the numerator includes pregnancies not included in the denominator (e.g., fetal losses, miscarriages, terminations) in the second paragraph of Methods, but this point is not addressed there and would be more appropriate in the discussion--i.e., the fact that the denominator would ideally include all pregnancies, not just all live births.
At the end of the second paragraph of method we indicate that rates are calculated as follows: "We estimated total prevalence rates (congenital anomalies in liveborns, foetal deaths and induced abortions divided by the total number of births) and prevalence rates at birth (congenital anomalies in liveborns and foetal deaths divided by the total number of births)". Thus, the denominator includes all births, live and still, and terminations and miscarriages are not included. We do not have the total number of terminations and miscarriages in the period of study, but even if it they were available, we do not think they should be added to the denominator because miscarriages and terminations not related to a prenatal diagnosis lack a diagnosis of congenital anomaly and, thus, none of them could ever be added to the numerator.
-The study limitations are not fully addressed in the discussion. 6 -It would be helpful to have a table listing the defects included in the study by group (nervous system, etc.) with the number of cases in each group. Having these numbers readily available for the reader would be preferable to a reference. The number of cases by group is in the second column of table 2
7. I noted that the paper requires further specialist statistical review, but only if that has not already been done. B Ibañez (PhD.), one of the co-authors, is a PhD statistician expert in modeling health data
